Gastroenterology Practice Questions

Q: Which of the following is associated with Autoimmune hepatitis?

Anti LKM antibody. **Explanation:** Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterized by elevated serum globulins and the presence of specific autoantibodies [1]. It is broadly classified into two types based on serological markers: * **Type 1 AIH:** The most common form, typically seen in adults [1]. It is associated with **ANA (Anti-nuclear antibody)** and/or **ASMA (Anti-smooth muscle antibody)**. * **Type 2 AIH:** More common in children and adolescents. It is characterized by the presence of **Anti-LKM1 (Liver-Kidney Microsomal type 1)** antibodies and/or **Anti-LC1 (Liver Cytosol type 1)** antibodies. **Analysis of Options:** * **A. Anti LKM antibody (Correct):** This is the hallmark marker for Type 2 AIH. It targets the cytochrome P450 2D6 enzyme. * **B, C, & D (Incorrect in context):** While ANA (Option B), ANCA (Option C - specifically p-ANCA), and SLA/LP (Option D - Soluble Liver Antigen) are all associated with AIH, the question asks "which is associated" in a single-best-answer format [3]. In many standard NEET-PG patterns, Anti-LKM is frequently tested as the specific differentiator for Type 2 AIH. *Note: Technically, all four options can be associated with AIH; however, Anti-LKM is a classic high-yield diagnostic marker.* **High-Yield Clinical Pearls for NEET-PG:** 1. **Type 1 AIH:** ANA (+), ASMA (+), HLA-DR3/DR4 association. 2. **Type 2 AIH:** Anti-LKM1 (+), Anti-LC1 (+), more aggressive clinical course. 3. **SLA/LP Antibody:** The most specific marker for AIH; patients are often ANA/ASMA negative. 4. **Treatment:** Corticosteroids (Prednisolone) are the mainstay, often combined with Azathioprine [2]. 5. **Histology:** Look for **"Interface Hepatitis"** (piecemeal necrosis) and plasma cell infiltration [2].

Q: All of the following are important clinical manifestations of hepatocellular carcinoma EXCEPT?

Jaundice. Hepatocellular Carcinoma (HCC) typically arises in the setting of chronic liver disease or cirrhosis. While it presents with several systemic and localized symptoms, **Jaundice (Option A)** is considered an **uncommon** or late manifestation of the tumor itself [1, 2]. When jaundice occurs in an HCC patient, it is usually due to underlying end-stage cirrhosis or massive tumor infiltration causing biliary obstruction, rather than being a primary presenting feature of the malignancy [1]. **Analysis of other options:** * **Abdominal Pain (Option B):** This is the most common presenting symptom. It is usually a dull, aching pain in the right upper quadrant caused by the rapid expansion of the liver capsule. * **Abdominal Mass (Option C):** A palpable, firm, and irregular liver mass or generalized hepatomegaly is a classic physical finding in HCC [2]. * **Ascites (Option D):** The sudden development of ascites or the rapid worsening of pre-existing ascites in a stable cirrhotic patient is a high-yield clinical "red flag" for the development of HCC [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common symptom:** Abdominal pain. * **Most common sign:** Hepatomegaly [2]. * **Paraneoplastic syndromes:** HCC is associated with erythrocytosis (due to EPO production), hypoglycemia, and hypercalcemia. * **Auscultation:** A hepatic bruit or friction rub over the liver is highly suggestive of HCC. * **Tumor Marker:** Alpha-fetoprotein (AFP) >400 ng/mL is highly suggestive, though not definitive. * **Triad of HCC:** RUQ pain, weight loss, and a palpable mass.

Q: A 28-year-old pregnant female complains of hematemesis after an episode of vomiting. Upper GI endoscopy reveals a specific appearance. What is the most common site of this condition?

Cardia. ***Cardia*** - **Mallory-Weiss tears** occur most commonly at the **cardia** (gastric side of the gastroesophageal junction), with approximately **75% of tears** located on the gastric mucosa. - The **cardia** is the most vulnerable site due to the sudden increase in **intragastric pressure** during forceful vomiting, especially in pregnant women with increased intra-abdominal pressure. *Gastroesophageal junction* - While the **GEJ** is involved in Mallory-Weiss syndrome, it refers to the **straddling zone** between esophagus and stomach rather than the specific anatomical site. - The term is less precise as it encompasses both esophageal and gastric sides, whereas the **cardia** specifically identifies the gastric location. *Lower 1/3 of the esophagus* - Only about **20-25% of Mallory-Weiss tears** occur in the **distal esophagus**, making it less common than the cardia. - **Esophageal tears** are more associated with **Boerhaave syndrome** (full-thickness rupture) rather than mucosal tears. *Lesser curvature of the stomach* - The **lesser curvature** is not typically involved in **Mallory-Weiss tears**, which are longitudinal mucosal lacerations. - This location is more commonly associated with **peptic ulcer disease** and **gastric adenocarcinoma**, not pressure-related mucosal tears.

Q: What is the first-line treatment for a severe exacerbation of ulcerative colitis?

Corticosteroids. ### Explanation The management of Ulcerative Colitis (UC) is stratified based on the severity of the disease (Truelove and Witts criteria). For a **severe exacerbation**, the primary goal is to induce rapid remission and prevent complications like toxic megacolon. **1. Why Corticosteroids are the Correct Answer:** Systemic corticosteroids (e.g., IV Hydrocortisone or Methylprednisolone) are the **gold standard first-line therapy** for inducing remission in severe UC [1]. They possess potent anti-inflammatory properties that act rapidly to reduce mucosal inflammation. According to clinical guidelines, if a patient does not respond to IV steroids within 3–5 days, they are considered "steroid-refractory," and rescue therapy is initiated. **2. Analysis of Incorrect Options:** * **A. Sulfasalazine:** This is a 5-ASA compound used primarily for **maintenance** of remission or for treating **mild-to-moderate** active disease [1]. It is insufficient for severe exacerbations. * **C. Infliximab:** This is an anti-TNF agent used as **"rescue therapy"** if the patient fails to respond to initial IV corticosteroids. It is not the first-line choice. * **D. Cyclosporine:** Similar to Infliximab, this calcineurin inhibitor is reserved for **steroid-refractory** severe UC as a bridge to long-term maintenance therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Truelove and Witts Criteria for Severe UC:** >6 bloody stools/day + systemic toxicity (Fever >37.8°C, Tachycardia >90 bpm, Anemia 30 mm/hr). * **Drug of Choice for Maintenance:** Mesalamine (5-ASA) is preferred over Sulfasalazine due to fewer side effects [1]. * **Toxic Megacolon:** A dreaded complication of severe UC; diagnosed when colonic dilatation is **>6 cm** on X-ray. * **Surgery:** Total proctocolectomy with Ileal Pouch-Anal Anastomosis (IPAA) is the curative surgical procedure of choice.

Q: What is the cause of pruritus in primary biliary cirrhosis?

Transient receptor potential vanilloid 1 (TRPV1). Pruritus is a common and distressing symptom of **Primary Biliary Cholangitis (PBC)**, formerly known as Primary Biliary Cirrhosis [1]. The pathophysiology involves the accumulation of cholestatic pruritogens (such as bile acids and lysophosphatidic acid) that activate specific neural pathways [2]. **Why TRPV1 is correct:** Recent research has identified **Transient Receptor Potential Vanilloid 1 (TRPV1)**, a non-selective cation channel found on sensory neurons, as a key mediator in cholestatic itch [2]. Pruritogens like **Lysophosphatidic Acid (LPA)**, formed by the enzyme autotaxin, activate these TRPV1 channels on peripheral nerve endings, leading to the transmission of the itch sensation to the central nervous system. **Analysis of Incorrect Options:** * **A. TLR4:** This is a pattern recognition receptor involved in innate immunity and the inflammatory response to LPS (endotoxin), not the primary mediator of pruritus. * **B. GLP-1:** This is an incretin hormone involved in glucose homeostasis and insulin secretion. * **D. GRP:** While Gastrin-releasing peptide is a known neurotransmitter in the spinal cord's "itch circuit," the specific peripheral trigger mechanism highlighted in recent PBC studies emphasizes the role of the TRPV1 channel. **High-Yield Clinical Pearls for NEET-PG:** * **First-line treatment for PBC pruritus:** Cholestyramine (bile acid sequestrant). * **Second-line/Alternative treatments:** Rifampicin (induces P450 to metabolize pruritogens), Naltrexone (opioid antagonist), and Sertraline (SSRI). * **Diagnostic Marker:** Anti-Mitochondrial Antibody (AMA) is positive in >95% of cases [3]. * **Key Enzyme:** **Autotaxin** levels correlate with the severity of cholestatic itch.

Q: What is the best diagnostic test for esophageal motility disorders?

Manometry. **Explanation:** **Esophageal Manometry** is the **gold standard** and best diagnostic test for evaluating esophageal motility disorders (e.g., Achalasia cardia, Diffuse Esophageal Spasm, Nutcracker esophagus) [1]. It directly measures the pressure, timing, and coordination of the Lower Esophageal Sphincter (LES) and the esophageal body during swallowing. High-resolution manometry (HRM) is the modern iteration, providing a "topographic map" (Chicago Classification) to precisely categorize these disorders [1]. **Analysis of Incorrect Options:** * **Barium studies:** While often the initial screening test (showing the "bird’s beak" appearance in Achalasia or "corkscrew" esophagus in DES), it is a structural/radiological study and cannot definitively quantify pressure or motor function [1]. * **Esophagoscopy:** Primarily used to rule out mechanical obstructions or "pseudoachalasia" (malignancy at the GE junction) [1]. It cannot diagnose motility issues as the esophagus often appears normal or merely dilated. * **24-hour pH monitoring:** This is the gold standard for diagnosing **Gastroesophageal Reflux Disease (GERD)**, not motility disorders. It measures acid exposure time but does not assess peristalsis. **High-Yield Clinical Pearls for NEET-PG:** * **Achalasia Cardia:** Characterized on manometry by **incomplete LES relaxation** (Integrated Relaxation Pressure >15 mmHg) and **aperistalsis** in the distal esophagus [1]. * **Nutcracker Esophagus:** Characterized by high-amplitude peristaltic contractions (>180 mmHg) [1]. * **Initial vs. Best:** For dysphagia, the initial test is often Barium Swallow or Endoscopy, but the **most definitive/best** test for motility is always Manometry [1].

Question 1

Which of the following is associated with Autoimmune hepatitis?

Accepted Answer

Anti LKM antibody

Answer

ANA

Answer

ANCA

Answer

SLA-antibody

Question 2

All of the following are important clinical manifestations of hepatocellular carcinoma EXCEPT?

Accepted Answer

Jaundice

Answer

Abdominal pain

Answer

Abdominal mass

Answer

Ascites

Question 3

A 28-year-old pregnant female complains of hematemesis after an episode of vomiting. Upper GI endoscopy reveals a specific appearance. What is the most common site of this condition?

Accepted Answer

Cardia

Answer

Gastroesophageal junction

Answer

Lower 1/3 of the esophagus

Answer

Lesser curvature of the stomach

Question 4

What is the first-line treatment for a severe exacerbation of ulcerative colitis?

Accepted Answer

Corticosteroids

Answer

Sulfasalazine

Answer

Infliximab

Answer

Cyclosporine

Question 5

What is true about ulcerative colitis?

Accepted Answer

Involves the rectum and then extends proximally throughout the colon.

Answer

Involves only the colon.

Answer

Skip lesions are seen.

Answer

The ileum is not involved.

Question 6

In patients who have undergone appendicectomy, which of the following conditions is less likely to develop?

Accepted Answer

Ulcerative colitis

Answer

Crohn's disease

Answer

Both

Answer

None

Question 7

What is the cause of pruritus in primary biliary cirrhosis?

Accepted Answer

Transient receptor potential vanilloid 1 (TRPV1)

Answer

Toll-like receptor 4 (TLR4)

Answer

Glucagon-like peptide 1 (GLP-1)

Answer

Gastrin-releasing peptide (GRP)

Question 8

Colonic pseudo obstruction occurs in all, EXCEPT:

Accepted Answer

Hyperthyroidism

Answer

Diabetes mellitus

Answer

Dermatomyositis

Answer

Scleroderma

Question 9

What is the treatment for diffuse esophageal spasm?

Accepted Answer

Nitrates

Answer

Pneumatic dilatation

Answer

Oxybutynin

Answer

Botulinum toxin and pneumatic dilation

Question 10

What is the best diagnostic test for esophageal motility disorders?

Accepted Answer

Manometry

Answer

Barium studies

Answer

Esophagoscopy

Answer

24-hour pH monitoring

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?